文献速递肝胆胰外科围术期管理与 ERAS

选择性流出控制技术辅助腹腔镜肝切除治疗右后上区肝细胞癌的病例系列研究

Application of selective outflow control technique-assisted laparoscopic hepatectomy for hepatocellular carcinoma in the right posterior superior area: a case series study (with video).
PubMed 文献 · Surg Endosc · 2026-07-13

本研究回顾性分析22例2024年1月至2026年1月接受选择性流出控制(SOC)技术辅助腹腔镜肝切除的右后上区(7、8段)肝细胞癌患者,评估其安全性、技术可行性和围术期结局。结果显示全部手术腹腔镜完成无中转,中位手术时间233.0分钟、中位估计出血量200 mL,全部实现R0切除,中位切缘1.5 cm,Clavien-Dindo I-II级并发症占59.1%,III级及以上占9.9%(2例IIIa级症状性胸腔积液需经皮引流),无围术期死亡或30天再入院。

要点

  • SOC技术按静脉受累范围分层为RHV阻断法和全流出道阻断法,实现个体化血管控制。
  • 22例右后上区HCC患者全部腹腔镜完成,无中转开腹。
  • 全部R0切除,中位切缘1.5 cm,无围术期死亡或30天再入院。

核心结论

  • SOC辅助腹腔镜肝切除是治疗右后上区肝细胞癌安全、技术可行且可重复的策略。
  • 其分层框架实现个体化血管控制,有助于精确R0切除并安全处理解剖复杂肿瘤。

研究设计与样本

  • 回顾性分析2024年1月至2026年1月连续22例接受SOC辅助腹腔镜肝切除的右后上区肝细胞癌患者。
  • 术前采用三维重建和基于区域的模拟指导个体化手术规划。
  • 根据静脉受累程度将SOC策略分层为RHV阻断法(肿瘤累及RHV但保留IVC壁)和全流出道阻断法(肿瘤累及IVC或RHV-IVC汇合处)。

主要发现

  • 全部手术腹腔镜完成,无中转开腹。
  • 中位手术时间233.0分钟,中位估计出血量200 mL。
  • 全部患者实现R0切除,中位手术切缘1.5 cm。
  • Clavien-Dindo I-II级轻微术后并发症发生率为59.1%。
  • III级及以上严重并发症发生率为9.9%,包括2例IIIa级症状性胸腔积液需经皮引流,均顺利恢复。

关键数值与推荐

  • RHV阻断法适用于肿瘤累及RHV但保留IVC壁者。
  • 全流出道阻断法适用于肿瘤累及IVC或RHV-IVC汇合处者。

临床怎么用

  • 对右后上区(7、8段)肝细胞癌,术前可行三维重建和区域模拟规划。
  • 根据肿瘤与RHV、IVC的解剖关系选择RHV阻断法或全流出道阻断法。
  • SOC辅助腹腔镜肝切除可作为解剖复杂肝切除的血管管理策略。

局限性

  • 回顾性病例系列研究,样本量22例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) involving the right posterosuperior area (segments 7 and 8) remains technically demanding because of the deep anatomical location of these lesions and their close relationship to the right hepatic vein (RHV) and inferior vena cava (IVC). This study evaluated the safety, technical feasibility, and perioperative outcomes of a novel stratified selective outflow control (SOC) technique developed to optimize vascular management during complex laparoscopic hepatectomy. METHODS: A retrospective analysis was performed of 22 consecutive patients who underwent SOC-assisted LLR for HCC located in the right posterosuperior area between January 2024 and January 2026. Preoperative three-dimensional (3D) reconstruction and territory-based simulation were used to guide individualized operative planning. According to the extent of venous involvement, the SOC strategy was stratified into two anatomical approaches: the RHV Occlusion method, applied to tumors involving the RHV while sparing the IVC wall, and the Total Outflow Occlusion method, reserved for tumors involving the IVC or the RHV-IVC confluence. RESULTS: All procedures were completed laparoscopically without conversion to open surgery. The median operative duration was 233.0 min, and the median estimated blood loss was 200 mL. R0 resection was achieved in all patients, with a median surgical margin of 1.5 cm. Minor postoperative complications (Clavien-Dindo grade I-II) occurred in 59.1% of patients. Major complications (grade ≥ III) were limited to 9.9% and consisted of 2 cases of grade IIIa symptomatic pleural effusion requiring percutaneous drainage, both of which resolved successfully. No perioperative mortalities or 30-day readmissions occurred. CONCLUSIONS: SOC-assisted LLR represents a safe, technically feasible, and reproducible strategy for HCC in the right posterosuperior segments. Its stratified framework enables individualized vascular control, facilitates precise R0 resection, and supports safe management of anatomically complex tumors.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Xie Q, Zhang B, Tan YC, et al. Application of selective outflow control technique-assisted laparoscopic hepatectomy for hepatocellular carcinoma in the right posterior superior area: a case series study (with video). Surg Endosc. 2026. PMID: 42443677. doi:10.1007/s00464-026-12995-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。